Share on LinkedInShare on LinkedIn

ARTICLE · 04 MARCH 2009

Exclusive Marketing Rights Revisited In India

Interest in the repealed exclusive marketing rights provisions has been revived by a Supreme Court ruling which clarifies the effect of the repeal on the litigation of pending and decided applications

IndiaIntellectual Property

Originally published in IP in The Life Sciences Industries 2009

Interest in the repealed exclusive marketing rights provisions has been revived by a Supreme Court ruling which clarifies the effect of the repeal on the litigation of pending and decided applications

The Dunkel Draft - the foundation of the World Trade Organisation (WTO) - proposed that countries which did not offer product patents for pharmaceuticals and agricultural chemicals as of 1st January 1995 should provide a pipeline system for accepting product patent applications (the "mailbox provision") and grant exclusive marketing rights (EMR) on certain mailbox applications. Article 65.4 of the Agreement on Trade- Related Aspects of Intellectual Property Rights (TRIPs) provided that developing countries which did not grant patents for pharmaceuticals and agrochemicals would be required to introduce a product patent regime within 10 years. In the interim, these countries were expected to provide

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from